FOLFIRI+bevacizumab induction chemotherapy followed by bevacizumab or observation in metastatic colorectal cancer, a phase III trial (PRODIGE 9--FFCD 0802).

Authors :: Aparicio T
Linot B
Le Malicot K
Bouché O
Boige V
François E
Ghiringhelli F
Legoux JL
Ben Abdelghani M
Phelip JM
Faroux R
Dahan L
Taieb J
Bedenne L
Source :: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2015 Apr; Vol. 47 (4), pp. 271-2. Date of Electronic Publication: 2015 Jan 20.
Publication Year :: 2015

Subjects :: Angiogenesis Inhibitors therapeutic use
Camptothecin analogs & derivatives
Camptothecin therapeutic use
Clinical Trials, Phase III as Topic
Fluorouracil therapeutic use
Humans
Leucovorin therapeutic use
Neoplasm Metastasis
Randomized Controlled Trials as Topic
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Bevacizumab therapeutic use
Colorectal Neoplasms diagnosis
Colorectal Neoplasms drug therapy
Colorectal Neoplasms secondary
Induction Chemotherapy methods

Language :: English
ISSN :: 1878-3562
Volume :: 47
Issue :: 4
Database :: MEDLINE
Journal :: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Publication Type :: Report
Accession number :: 25677925
Full Text :: https://doi.org/10.1016/j.dld.2015.01.146

Full Text Access

Tools